|
GOLGA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.461600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.077000E-01 |
| Normal-vs-Stage2 |
5.031800E-01 |
| Normal-vs-Stage3 |
5.649700E-02 |
| Normal-vs-Stage4 |
6.383200E-01 |
| Stage1-vs-Stage2 |
8.540600E-01 |
| Stage1-vs-Stage3 |
2.122000E-02 |
| Stage1-vs-Stage4 |
4.534200E-01 |
| Stage2-vs-Stage3 |
5.470400E-02 |
| Stage2-vs-Stage4 |
4.047400E-01 |
| Stage3-vs-Stage4 |
4.827600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.599800E-01 |
| Normal-vs-AfricanAmerican |
8.979400E-01 |
| Normal-vs-Asian |
9.799500E-02 |
| Caucasian-vs-AfricanAmerican |
5.907600E-01 |
| Caucasian-vs-Asian |
2.907000E-01 |
| AfricanAmerican-vs-Asian |
3.464000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.982400E-01 |
| Normal-vs-Female |
4.710400E-01 |
| Male-vs-Female |
8.573000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.382800E-01 |
| Normal-vs-Extreme_Weight |
9.417400E-01 |
| Normal-vs-Obese |
5.929600E-01 |
| Normal-vs-Extreme_Obese |
4.511800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.236400E-01 |
| Normal_Weight-vs-Obese |
3.612800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.476600E-01 |
| Extreme_Weight-vs-Obese |
6.532800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.123000E-01 |
| Obese-vs-Extreme_Obese |
7.295600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.860400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.922170E-02 |
| Normal-vs-Age(61-80Yrs) |
9.129400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.459400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.210100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.877000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.922400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.069700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.244200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.652000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.400730E-03 |
| Normal-VS-Type2 PRCC |
6.060300E-02 |
| Normal-VS-KIRP CIMP |
3.5246999999794E-06 |
| Normal-VS-Unclassified PRCC |
4.181200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.57939999999779E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.53779999998183E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
4.191800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.564000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.758000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.175900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.893010E-01 |
| Normal-vs-N1 |
1.588160E-01 |
| Normal-vs-N2 |
3.638200E-04 |
| N0-vs-N1 |
5.586400E-01 |
| N0-vs-N2 |
7.099600E-02 |
| N1-vs-N2 |
2.210800E-01 |
|
|
